AIA - CA125 near me in Ajmer

The AIA - CA125 is designed to identify potential cancer. It measures the level of cancer antigen 125 (CA125) protein, found in the ovaries, fallopian tubes, and body lining. It is most commonly used as a biomarker to help evaluate the presence or progression of ovarian cancer. In addition to ovarian cancer, high CA125 levels are found in cervical, liver, pancreatic, lung, colon, stomach, biliary tract, uterine, fallopian tube, breast, and endometrial cancers. However, CA125 can also rise in non-cancerous conditions, including endometriosis, pelvic inflammatory disease, menstruation, and some benign ovarian cysts, making it important to interpret results within a broader clinical context. For individuals undergoing cancer treatment, the CA125 test is often used to monitor how well therapy is working or to detect potential recurrence. In high-risk individuals or those with concerning symptoms, it may support early assessment and guide further diagnostic steps. By measuring changes in CA125 levels over time, this test provides valuable insights that help inform ongoing health and treatment decisions.

Disclaimer: Tumor markers (e.g., CA 125) are specialized tests that should not be used alone for cancer diagnosis due to potential false positives and negatives. They are most useful for monitoring high-risk patients, tracking disease progression, and assessing treatment response. They are unsuitable for vague symptoms or general screening because of their lack of specificity and potential elevation in benign conditions. Additionally, some procedures can temporarily raise tumor marker levels, so consult your doctor about the best timing for these tests.